Abstract:
Risk management is a major issue for public companies and those on the IPO path as well private companies. Ignore it at your peril. Emerging nanotechnology companies tend to focus on issues such as growth strategies, new product development and patent applications. Risk management is not viewed as critical for most senior nanotech managers and founders.